As passengers from a cruise ship linked to an Andes hantavirus outbreak return home, health experts emphasize the significant differences in transmission dynamics compared to COVID-19, underscoring the importance of understanding unique viral behaviors.
Amid the return of passengers from a recent cruise associated with an outbreak of Andes hantavirus, comparisons to the early phases of the COVID-19 pandemic have surfaced. However, experts caution that such parallels may not be accurate, primarily due to the distinct transmission characteristics of the Andes virus as compared to SARS-CoV-2, the virus responsible for COVID-19.
Dr. Lina Moses, an associate professor at Tulane University’s Celia Scott Weatherhead School of Public Health and Tropical Medicine and a former advisor to the World Health Organization on COVID-19, provided critical insights into the Andes virus during an interview. Dr. Moses pointed out that the Andes virus does not spread nearly as effectively as SARS-CoV-2, highlighting a fundamental difference in how each virus is transmitted.
Understanding Hantavirus and Its Transmission
The Andes virus belongs to the hantavirus family, which is primarily transmitted from rodents to humans. Unlike other hantaviruses, the Andes virus possesses the unique capability of person-to-person transmission; however, this type of spread requires very close contact, similar to interactions among caregivers or those sharing confined spaces. In contrast, COVID-19 is known for its efficient respiratory transmission, often spreading from individuals who are asymptomatic or unaware of their infection status.
Dr. Moses remarked, “We do have the advantage of historical comparison, and the hantavirus transmission we’re seeing is much less efficient than what we saw in the early stages of COVID-19.” She elaborated that if the Andes virus behaved similarly to SARS-CoV-2 or measles, one would expect to see a higher rate of infection among passengers on the cruise ship, yet current data does not support that expectation.
The Incubation Period and Public Health Monitoring
The Andes virus has a notably lengthy incubation period, estimated to range from six to eight weeks from exposure to the manifestation of symptoms. This prolonged timeline may raise concerns among health officials and the public; however, Dr. Moses explained that a long incubation period allows for a clearer monitoring schedule after exposure. Public health officials can better assess when individuals are no longer at risk of developing the disease.
Crucially, there is no documented evidence of asymptomatic transmission of the Andes virus, which further distinguishes it from COVID-19. The latter’s rapid spread was significantly fueled by asymptomatic and presymptomatic individuals, complicating containment efforts. Dr. Moses underscored that people who feel well are not thought to be silently propagating the Andes virus, which alleviates some concerns about widespread, undetected transmission.
Vigilance and Historical Context
Dr. Moses cautioned that a primary concern would arise if cases began to emerge outside the established contact network. Such instances would suggest that the virus might be spreading beyond the individuals currently monitored by public health officials. “It’s understandable during outbreaks to be reactive to the lessons we’ve learned. It’s always important to be vigilant about this,” she stated.
Despite these concerns, she emphasized the importance of historical context in understanding the Andes virus, adding, “We have decades of information about the Andes virus, and we’ve seen nothing in this outbreak to tell us it has mutated in a way that improves its human-to-human transmission.” This perspective highlights the significance of maintaining a level-headed approach to monitoring the outbreak.
Implications for Public Health
Dr. Moses is renowned for her extensive expertise in zoonotic diseases—those that transfer from animals to humans—backed by decades of hands-on public health experience. Her work has included disease surveillance and community-based interventions aimed at addressing outbreaks such as Ebola, Lassa fever, and mpox. This extensive background informs her perspective on the current Andes hantavirus situation.
As the outbreak continues to develop, public health officials will closely monitor the progress of the Andes virus, applying lessons learned from past epidemics while remaining cognizant of the specific characteristics that define this virus. The response will be informed by historical data, which underscores the importance of vigilance without inciting undue panic among the public.
The return of cruise passengers amid this outbreak serves as a reminder of the complex dynamics involved in infectious disease transmission, as well as the critical role of accurate information in managing public health responses. Understanding the nuances of different viruses is essential for effective communication and action during health crises.
